APA (7th ed.) Citation

Tingting Ma, Yanli Dong, Lei Huang, Yuanxun Yang, Yan Geng, Fei Fei, . . . Juan Li. (2022). SHR2285, the first selectively oral FXIa inhibitor in China: Safety, tolerability, pharmacokinetics and pharmacodynamics combined with aspirin, clopidogrel or ticagrelor. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Tingting Ma, et al. SHR2285, the First Selectively Oral FXIa Inhibitor in China: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Combined with Aspirin, Clopidogrel or Ticagrelor. Frontiers Media S.A., 2022.

MLA (9th ed.) Citation

Tingting Ma, et al. SHR2285, the First Selectively Oral FXIa Inhibitor in China: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Combined with Aspirin, Clopidogrel or Ticagrelor. Frontiers Media S.A., 2022.